Ordinary Shares · CUSIP L01800108 · who reports it, how much, and how much it matters to them
13 of the 720 hedge fund managers we track reported shares of Alvotech (Nasdaq: ALVO) on Form 13F for 30 June 2026. Between them they reported USD 56m. The largest position belongs to Millennium Management, at USD 16m. The manager with the most riding on it is Littlejohn & Co., where it is 6.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Millennium Management6 funds on PPLI.com | USD 16m | 0.0% |
| 2 | Bracebridge Capital12 funds on PPLI.com | USD 15m | 0.3% |
| 3 | Farallon Capital Management56 funds on PPLI.com | USD 11m | 0.0% |
| 4 | Citadel Advisors32 funds on PPLI.com | USD 6.4m | 0.0% |
| 5 | Littlejohn & Co.15 funds on PPLI.com | USD 4.9m | 6.2% |
| 6 | Sona Asset Management (US)1 fund on PPLI.com | USD 1.3m | 0.0% |
| 7 | Hudson Bay Capital Management8 funds on PPLI.com | USD 879,000 | 0.0% |
| 8 | Lighthouse Investment Partners190 funds on PPLI.com | USD 461,000 | 0.0% |
| 9 | Oaktree Capital Management219 funds on PPLI.com | USD 362,000 | 0.0% |
| 10 | Marshall Wace LLP84 funds on PPLI.com | USD 265,000 | 0.0% |
| 11 | Tudor Investment Corporation10 funds on PPLI.com | USD 164,000 | 0.0% |
| 12 | Prelude Capital Management9 funds on PPLI.com | USD 52,129 | 0.0% |
| 13 | Sculptor Capital67 funds on PPLI.com | USD 5,242 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Littlejohn & Co. | USD 4.9m | 6.2% |
| 2 | Bracebridge Capital | USD 15m | 0.3% |
| 3 | Farallon Capital Management | USD 11m | 0.0% |
| 4 | Sona Asset Management (US) | USD 1.3m | 0.0% |
| 5 | Lighthouse Investment Partners | USD 461,000 | 0.0% |
| 6 | Millennium Management | USD 16m | 0.0% |
| 7 | Oaktree Capital Management | USD 362,000 | 0.0% |
| 8 | Prelude Capital Management | USD 52,129 | 0.0% |
| 9 | Hudson Bay Capital Management | USD 879,000 | 0.0% |
| 10 | Citadel Advisors | USD 6.4m | 0.0% |
Alvotech trades under the symbol ALVO on the Nasdaq. Its CUSIP, the code used on Form 13F, is L01800108.
13 of the 720 hedge fund managers PPLI.com tracks reported Alvotech shares on Form 13F for 30 June 2026. The largest reported positions were held by Millennium Management (USD 16m), Bracebridge Capital (USD 15m), Farallon Capital Management (USD 11m), Citadel Advisors (USD 6.4m) and Littlejohn & Co. (USD 4.9m).
13 managers in our coverage reported it, and between them they run 709 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Littlejohn & Co., where the position was 6.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Alvotech or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.